Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling
Colorectal cancer (CRC) is the third most frequent cancer and the second leading cause of cancer-related deaths globally. Evidence shows that over 90% of CRC cases are initiated by a deregulated Wingless Integrated Type-1 (WNT)/β-catenin signaling pathway. The WNT/β-catenin pathway also promotes CRC...
Hoofdauteurs: | Jude Tetteh Quarshie, Kwadwo Fosu, Nicholas Awuku Offei, Augustine Kojo Sobo, Osbourne Quaye, Anastasia Rosebud Aikins |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
MDPI AG
2023-07-01
|
Reeks: | Pharmaceuticals |
Onderwerpen: | |
Online toegang: | https://www.mdpi.com/1424-8247/16/7/1026 |
Gelijkaardige items
-
Cryptolepine and Nibima inhibit hepatitis B virus replication
door: Seth A. Domfeh, et al.
Gepubliceerd in: (2021-09-01) -
Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling
door: Seth A. Domfeh, et al.
Gepubliceerd in: (2021-06-01) -
Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley rats
door: Arnold Donkor Forkuo, et al.
Gepubliceerd in: (2017-12-01) -
Increasing the planting density of Cryptolepis sanguinolenta (Lindl.) Schlt increased root biomass and cryptolepine yield
door: Jacqueline Naalamle Amissah, et al.
Gepubliceerd in: (2024-05-01) -
Semi-Synthetic Analogues of Cryptolepine as a Potential Source of Sustainable Drugs for the Treatment of Malaria, Human African Trypanosomiasis, and Cancer
door: Yabalu Z. Abacha, et al.
Gepubliceerd in: (2022-04-01)